基本信息
浏览量:3
职业迁徙
个人简介
At AstraZeneca PLC, I was the Medical Science Director for AstraZeneca’s Boston site, responsible for the medical and clinical aspects of development of agents from chemical lead identification through clinical proof of concept in phase II. I was responsible for the design and interpretation of the entire clinical development plan for five agents. This position had global responsibilities with clinical trials in the US, Canada, European Union, Japan and Korea. I was a member of the Strategic Planning & Business Development as an ad hoc member and was the global Disease Area Clinical Expert for Hematology.
研究兴趣
论文共 293 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER RESEARCHno. 7 (2024)
Nature communicationsno. 1 (2024): 4091-4091
Cancer Researchno. 7_Supplement (2024)
Yiduo Hu,Azeet Narayan, Yunshan Xu, Julia Wolfe,Dennis Vu,Thi Trinh,Chaitanya Kantak,S Percy Ivy,Joseph Paul Eder,Yanhong Deng,Patricia LoRusso,Joseph W Kim,
Deborah Blythe Doroshow,Wei Wei,Meenakshi Mehrotra, Daniella Sia,Joseph Paul Eder,Ranjit Bindra, Jane Houldsworth,Patricia LoRusso,Zenta Walther
CANCER INVESTIGATIONno. 7 (2023): 646-655
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn